3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Prostatic Neoplasms
2
Lymphoma, Non-Hodgkin
2
Leukemia, Myeloid, Acute
2
Leukemia
2
Waldenstrom Macroglobulinemia
1
Urogenital Neoplasms
1
Triple Negative Breast Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Precancerous Conditions
1
Polycystic Ovary Syndrome
1
Neoplasms
1
Myelodysplastic-Myeloproliferative Diseases
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Prolymphocytic
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Kidney Neoplasms
1
Inflammatory Breast Neoplasms
1
Hodgkin Disease
1
Hemangioma, Cavernous, Central Nervous System
1
Heart Failure
1
Interventions
BNT162 Vaccine
2
2019-nCoV Vaccine mRNA-1273
2
tocilizumab
1
sotrovimab
1
proxalutamide
1
bemcentinib
1
Therapeutics
1
Surveys and Questionnaires
1
Standard of Care
1
Specimen Handling
1
Sodium Chloride
1
Radiotherapy
1
Patient Reported Outcome Measures
1
Janus Kinase Inhibitors
1
Influenza Vaccines
1
Hydroxychloroquine
1
HuMax-IL8
1
Gelsolin
1
Diagnostic Tests, Routine
1
Decision Support Techniques
1
COVID-19 Vaccines
1
Blood Specimen Collection
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
COVID-19
×
Atorvastatin
×
Clear all
No trials found.